← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Director Christopher A Marlett bought $45K of Cue Biopharma, Inc.

Bought$44,736
$4.74Price
9,438Shares
+1%Stake

What CUE did for a copier

Prices for CUE after this filing aren't in yet.

Christopher A Marlett's record

9 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Thu, Dec 20. Filed Fri, Dec 21, 7:22 AM ET, before the open. Not investment advice.